Valeo Pharma Inc.
Valeo Pharma Inc., a prominent Canadian pharmaceutical company, is headquartered in Laval, Quebec, with significant operations across North America. Founded in 2003, Valeo Pharma has established itself in the healthcare industry, focusing on the development and commercialisation of innovative prescription medications. The company’s core product offerings include a range of therapeutic solutions in areas such as oncology, neurology, and respiratory health, distinguished by their commitment to addressing unmet medical needs. Valeo Pharma has achieved notable milestones, including strategic partnerships and product launches that have solidified its market position. With a dedication to enhancing patient outcomes, Valeo Pharma continues to make strides in the pharmaceutical landscape, driven by a robust pipeline and a focus on quality and efficacy.
DitchCarbon Score
How does Valeo Pharma Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Chemicals industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Valeo Pharma Inc.'s score of 13 is higher than 58% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Valeo Pharma Inc.'s reported carbon emissions
Valeo Pharma Inc., headquartered in Canada, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete figures or defined goals, it is challenging to assess their current carbon footprint or climate strategy. However, as a participant in the pharmaceutical industry, Valeo Pharma is likely aware of the increasing importance of sustainability and may be exploring avenues to enhance their environmental performance in line with industry standards. Further information on their climate commitments or future initiatives may be forthcoming as they develop their sustainability strategies.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Valeo Pharma Inc. is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
